Sino Biopharmaceutical reported CNY76.87M in Interest Expense on Debt for its fiscal semester ending in June of 2024.





Interest Expense On Debt Change Date
Akebia Therapeutics 349.66M 12.86M Jun/2026
Alaunos Therapeutics USD 1.07M 215K Jun/2023
Avita Medical AUD 1.25M 100K Jun/2025
Cspc Pharmaceutical CNY 6.76M 3.43M Dec/2025
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Ionis Pharmaceuticals USD 18M 1000K Jun/2026
IQVIA Holdings USD 197M 5M Jun/2026
Jiangsu Hengrui CNY 254.59M 253.85M Sep/2025
Moderna USD 10.96B 527M Jun/2026
Organon & Co USD 108M 3M Jun/2026
Revvity USD 22.99M 1.73M Jun/2026
Sino Biopharmaceutical CNY 76.87M 114.23M Jun/2024
Tectonic Therapeutic USD 246.58M 246.56M Mar/2026
Viatris USD 120.7M 600K Jun/2026
Xeris Pharmaceuticals USD 6.88M 269K Mar/2026